Skip to content

The feasibility of 2-µm continuous-wave thulium laser for treating primary non-muscle-invasive bladder cancer

The feasibility of 2-µm continuous-wave thulium laser for treating primary non-muscle-invasive bladder cancer

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IOR-15006634
Enrollment
Unknown
Registered
2015-06-08
Start date
2006-01-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

primary non-muscle-invasive bladder cancer

Interventions

laser group :laser vaporesection for bladder tumor
TURBT group :Trans-urethral bladder tumor resection

Sponsors

Shanghai Jiaotong university affiliated 6th People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
45 Years to 86 Years

Inclusion criteria

Inclusion criteria: 1. Diagnosed as Ta or T1 bladder cancer; 2. Single or multiple papillary neoplasms should be found in the bladder with no upper urinary tract abnormalities; 3. Pelvic MRI, PET-CT should be performed to confirm the absence of extravesical extension, lymph node metastasis, or adjacent organ invasion.

Exclusion criteria

Exclusion criteria: 1. The evidence of tumor extended invasion or adjacent infiltratoion; 2. Lymphatic metastatis or distant metastasis; 3. Serious complication,which can not tolerate the anethesia or operation; 4. Can not finish the bladder irrigation; 5. Can not keep the regular follow up and cystoscopic examination.

Design outcomes

Primary

MeasureTime frame
Recurrence rates;Operation time;complication rate;

Countries

China

Contacts

Public ContactXin-Ru Zhang
13061764323@163.com+86 021-64369181-58372

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026